didn't hear anything about it - was 23-25 May
Are they really serious about starting OM ph3 and releasing interim results for HCC? Why do these things always seem like they are being pushed back? It's been three years now since that famous FDA panel meeting ... that's a long, long time between key events. Are they waiting really until there's one month operating cash left? It's not like there is the luxury of a deep-pocketed backer or partner, is there? Unfortunately they've proven pretty predictable so far - would rather that not be the case, but ...
Why do you say 'unpredictable'? There's been nothing unpredictable (unfortunately) about the pps for the better part of 3 yrs under this management -- which except for a few short-lived spikes has been straight down -- way, way down to where we are now
that was some spike - 10% of the float trading in 2-3 hours - you'd think they found a cure for cancer, or something (okay, sorry about that). But something's up, or at least someone thinks so, with these 2.2 mil shares. Let's see where we are a week from now - any takers? Anyone else feel like going on a limb, aiming for that elusive $1 print again ...?
Without meaningul communication and exposure in appropriate media and technical journal outlets the progress and promise of Chemostat could for the most part remain locked in a box, and will have done little to
excite and inform and Wall St. and garner interest among potential BP partners.
Thanks! Even with all the positive results and tumor response indications management could hope for, they still need for word to get out and to garner interest in widely read media and blog outlets both here and in Europe. Otherwise it stays locked in a box, with scant public awareness and investment interest aroused ... it's not only about the science but also about effective and timely communication, and skilled and experienced management teams are well aware of that.
What surprises me somewhat is that with the advances they've made with CS and tumor reponse and with patient safety why haven't we yet seen more coverage about it in the press - in Europe or the US? Especially considering the growing European response and that the treatment involves a significant unmet need. Without well-informed media coverage and interest it's difficult to generate the public awareness needed to spike investor involvement and to motivate the regulatory authorities.
Is that the same guy who quickly surfaces on the SA blog whenever an opportunity arises to spin a negative narrative about Soda? No doubt his paymasters, probably staring all day at their short positions, are already wondering when to expect the next great dissertation that might as well be titlled 'how can we try to distort reality this time'.
My Bed, Bath and Beyond in Manhattan was having in-store demonstrations and tastings this weekend and consumers were reacting enthusiastically. I tried a number of new flavors myself which impressed.
uh huh, yep, everybody's satisfied with management practices, operational decisions & current direction, etc., no disagreements, uh huh, yep
... may just be not more complicated than that at the end of the day - still with 11% stake in the company, nothing at all to sneeze at. CI also sold down some of his Apple stake. When he amassed these over-sized positions it was a different market all around. Makes sense to me, the trade, from both CI's and Nuan's position. Guess we'll see. Gd luck